A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer

Why Warburg Works: Lactate Controls Immune Evasion through GPR81

(2020) Kathrine Lundø et al.   Cell Metabolism

MiR‐210‐3p‐EphrinA3‐PI3K/AKT axis regulates the progression of oral cancer

(2020) Lin Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment

(2019) Ana C. Garrido-Castro et al.   Cancer Discovery

FOXK1 and FOXK2 regulate aerobic glycolysis

(2019) Valentina Sukonina et al.   NATURE

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

(2019) Xina Zhang et al.   Molecular Cancer

The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells

(2019) Mengjia He et al.   ONCOGENE

Triple negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition

(2019) Kaushik Das et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

miR‐210‐3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5‐fluorouracil

(2019) Erica Pranzini et al.   MOLECULAR CARCINOGENESIS

A five‐miRNA panel in plasma was identified for breast cancer diagnosis

(2019) Minghui Li et al.   Cancer Medicine

Hsa-miR-210-3p expression in breast cancer and its putative association with worse outcome in patients treated with Docetaxel

(2019) Barbara Pasculli et al.   Scientific Reports

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

(2019) Deepak Parashar et al.   Cell Reports

Transcriptional Regulation of the Warburg Effect in Cancer by SIX1

(2018) Ling Li et al.   CANCER CELL

Metazoan MicroRNAs

(2018) David P. Bartel   CELL

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer

(2018) Steven C. Eastlack et al.   Molecular Cancer

microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer

(2018) Sinae Kim et al.   ONCOGENE

Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to Both Tumorigenesis and Recurrence

(2018) Jinhua Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer

(2018) Sandra L. Romero-Cordoba et al.   Scientific Reports

The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism

(2018) Yixiao Feng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice

(2017) Shu-Heng Jiang et al.   GASTROENTEROLOGY

Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit

(2017) Matthew G. Costales et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway

(2017) Dong Ren et al.   Molecular Cancer

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

(2017) Rajesha Rupaimoole et al.   NATURE REVIEWS DRUG DISCOVERY

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Cytoglobin as a Biomarker in Cancer: Potential Perspective for Diagnosis and Management

(2015) Tatsha C. Bholah et al.   Biomed Research International

DNA damage induced activation of Cygb stabilizes p53 and mediates G1 arrest

(2014) Rince John et al.   DNA REPAIR

The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma

(2013) Zhien Feng et al.   HISTOPATHOLOGY

Targeting cellular metabolism to improve cancer therapeutics

(2013) Y Zhao et al.   Cell Death & Disease

Tumour-associated mutant p53 drives the Warburg effect

(2013) Cen Zhang et al.   Nature Communications

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors

(2012) Ji-Young Park et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

A Hypoxia-Induced Positive Feedback Loop Promotes Hypoxia-Inducible Factor 1  Stability through miR-210 Suppression of Glycerol-3-Phosphate Dehydrogenase 1-Like

(2011) T. J. Kelly et al.   MOLECULAR AND CELLULAR BIOLOGY

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

(2009) M. G. Vander Heiden et al.   SCIENCE